<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33565152</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1531-8249</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of neurology</Title><ISOAbbreviation>Ann Neurol</ISOAbbreviation></Journal><ArticleTitle>Prediction Model of Amyotrophic Lateral Sclerosis by Deep Learning with Patient Induced Pluripotent Stem Cells.</ArticleTitle><Pagination><StartPage>1226</StartPage><EndPage>1233</EndPage><MedlinePgn>1226-1233</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ana.26047</ELocationID><Abstract><AbstractText>In amyotrophic lateral sclerosis (ALS), early diagnosis is essential for both current and potential treatments. To find a supportive approach for the diagnosis, we constructed an artificial intelligence-based prediction model of ALS using induced pluripotent stem cells (iPSCs). Images of spinal motor neurons derived from healthy control subject and ALS patient iPSCs were analyzed by a convolutional neural network, and the algorithm achieved an area under the curve of 0.97 for classifying healthy control and ALS. This prediction model by deep learning algorithm with iPSC technology could support the diagnosis and may provide proactive treatment of ALS through future prospective research. ANN NEUROL 2021;89:1226-1233.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Imamura</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yada</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Yuishin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morita</LastName><ForeName>Mitsuya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Neurology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawata</LastName><ForeName>Akihiro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arisato</LastName><ForeName>Takayo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, National Hospital Organization Minamikyusyu Hospital, Kagoshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagahashi</LastName><ForeName>Ayako</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Enami</LastName><ForeName>Takako</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsukita</LastName><ForeName>Kayoko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Hideshi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-1405-0901</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagawa</LastName><ForeName>Masanori</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, North Medical Center, Kyoto Prefectural University of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Haruhisa</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-4736-9537</Identifier><AffiliationInfo><Affiliation>Medical-Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>iPSC-based Drug Discovery and Development Team, RIKEN BioResource Research Center, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Neurol</MedlineTA><NlmUniqueID>7707449</NlmUniqueID><ISSNLinking>0364-5134</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077321" MajorTopicYN="Y">Deep Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="Y">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="Y">Motor Neurons</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Nothing to report.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>10</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33565152</ArticleId><ArticleId IdType="pmc">PMC8247989</ArticleId><ArticleId IdType="doi">10.1002/ana.26047</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maurel C, Dangoumau A, Marouillat S, et al. Causative genes in amyotrophic lateral sclerosis and protein degradation pathways: a link to neurodegeneration. Mol Neurobiol 2018;55:6480&#x2013;6499.</Citation><ArticleIdList><ArticleId IdType="pubmed">29322304</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011;7:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pubmed">21989247</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteva A, Kuprel B, Novoa RA, et al. Dermatologist&#x2010;level classification of skin cancer with deep neural networks. Nature 2017;542:115&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">28117445</ArticleId></ArticleIdList></Reference><Reference><Citation>Causey JL, Zhang J, Ma S, et al. Highly accurate model for prediction of lung nodule malignancy with CT scans. Sci Rep 2018;8:9286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006355</ArticleId><ArticleId IdType="pubmed">29915334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kather JN, Pearson AT, Halama N, et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med 2019;25:1054&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7423299</ArticleId><ArticleId IdType="pubmed">31160815</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen EM, Yang SJ, Ando DM, et al. In Silico labeling: predicting fluorescent labels in unlabeled images. Cell 2018;173:792&#x2013;803.e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6309178</ArticleId><ArticleId IdType="pubmed">29656897</ArticleId></ArticleIdList></Reference><Reference><Citation>Okita K, Yamakawa T, Matsumura Y, et al. An efficient nonviral method to generate integration&#x2010;free human&#x2010;induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 2013;31:458&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">23193063</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada Y, Kume K, Matsuda Y, et al. Genetic screening for potassium channel mutations in Japanese autosomal dominant spinocerebellar ataxia. J Hum Genet 2020;65:363&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">31907387</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21&#x2010;linked ALS&#x2010;FTD. Neuron 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Philbrick KA, Yoshida K, Inoue D, et al. What does deep learning see? Insights from a classifier trained to predict contrast enhancement phase from CT images. AJR Am J Roentgenol 2018;211:1184&#x2013;1193.</Citation><ArticleIdList><ArticleId IdType="pubmed">30403527</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampasek L, Goldenberg A. TensorFlow: biology's gateway to deep learning? Cell Syst 2016;2:12&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">27136685</ArticleId></ArticleIdList></Reference><Reference><Citation>Murakami N, Imamura K, Izumi Y, et al. Proteasome impairment in neural cells derived from HMSN&#x2010;P patient iPSCs. Mol Brain 2017;10:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310050</ArticleId><ArticleId IdType="pubmed">28196470</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuzono K, Imamura K, Murakami N, et al. Antisense oligonucleotides reduce RNA foci in spinocerebellar ataxia 36 patient iPSCs. Mol Ther Nucleic Acids 2017;8:211&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5504081</ArticleId><ArticleId IdType="pubmed">28918022</ArticleId></ArticleIdList></Reference><Reference><Citation>Badrinarayanan V, Kendall A, Cipolla R. SegNet: a deep convolutional encoder&#x2010;decoder architecture for image segmentation. IEEE Trans Pattern Anal Mach Intell 2017;39:2481&#x2013;2495.</Citation><ArticleIdList><ArticleId IdType="pubmed">28060704</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohman F, Park H, Robinson C, Chau DH. Summit: scaling deep learning interpretability by visualizing activation and attribution summarizations. IEEE Trans Vis Comput Graph 2020;26:1096&#x2013;1106.</Citation><ArticleIdList><ArticleId IdType="pubmed">31443005</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao C, Liu F, Tan H, et al. Deep learning and its applications in biomedicine. Genomics Proteomics Bioinformatics 2018;16:17&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6000200</ArticleId><ArticleId IdType="pubmed">29522900</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SJ, Lipnick SL, Makhortova NR, et al. Applying deep neural network analysis to high&#x2010;content image&#x2010;based assays. SLAS Discov 2019;24:829&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6710615</ArticleId><ArticleId IdType="pubmed">31284814</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K, Izumi Y, Watanabe A, et al. The Src/c&#x2010;Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med 2017;9:eaaf3962.</Citation><ArticleIdList><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrooten M, Smetcoren C, Robberecht W, Van Damme P. Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study. Ann Neurol 2011;70:79&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">21437935</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, et al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol 2021;17:104&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: a systematic review. Arch Neurol 2012;69:1410&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pubmed">22892641</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagliardi D, Meneri M, Saccomanno D, et al. Diagnostic and prognostic role of blood and cerebrospinal fluid and blood neurofilaments in amyotrophic lateral sclerosis: a review of the literature. Int J Mol Sci 2019;20:4152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6747516</ArticleId><ArticleId IdType="pubmed">31450699</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayakumar UG, Milla V, Cynthia Stafford MY, et al. A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS. Front Neurol 2019;10:400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6527847</ArticleId><ArticleId IdType="pubmed">31139131</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards D, Morren JA, Pioro EP. Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis. J Neurol Sci 2020;417:117054.</Citation><ArticleIdList><ArticleId IdType="pubmed">32763509</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2010;Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 2010;81:1324&#x2013;1326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres&#x2010;Ciga S, Noyce AJ, Hemani G, et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol 2019;85:470&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo JM, Anderssen E, Walsh RM, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012;151:1617&#x2013;1632.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3608203</ArticleId><ArticleId IdType="pubmed">23260147</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J, Imhof S, Wainger BJ. Modeling cell&#x2010;autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol Dis 2020;134:104680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, et al. Modeling sporadic ALS in iPSC&#x2010;derived motor neurons identifies a potential therapeutic agent. Nat Med 2018;24:1579&#x2013;1589.</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt MF, Martinez FJ, Wright S, et al. A cellular model for sporadic ALS using patient&#x2010;derived induced pluripotent stem cells. Mol Cell Neurosci 2013;56:355&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Harrison PJ, Wieslander H, et al. Deep learning in image cytometry: a review. Cytometry A 2019;95:366&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590257</ArticleId><ArticleId IdType="pubmed">30565841</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath S. DNA methylation age of human tissues and cell types. Genome Biol 2013;14:R115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015143</ArticleId><ArticleId IdType="pubmed">24138928</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>